MAPT and Alzheimer disease: In order to clarify whether there is a correlation between plasma markers and urine formaldehyde in AD spectrum, we tested the blood biomarkers of AD pathology (Aβ40, Aβ42, T-tau, and P-tau181) and axonal injury (NfL) by Simoa assays.